XENE - Xenon Pharmaceuticals Announces Upcoming Investor Webinar with Leading Key Opinion Leaders to Discuss XEN1101 and Major Depressive Disorder | Benzinga
VANCOUVER, British Columbia, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neurology-focused biopharmaceutical company, today announced that the company will host an investor webinar with two leading key opinion leaders (KOLs) focused on major depressive disorder.
| Webinar: |
| "XEN1101 and the Major Depressive Disorder (MDD) Landscape: A Discussion with KOLs" |
| Date: |
| Tuesday, September 19, 2023 |
| Time: |
| 11:30 am – 1 pm ET Eastern Time (8:30 am – 11 am Pacific Time) |
| Link: |
| Participants can register and access the webinar on the Investors section of Xenon's website. |
| Format: |
| Questions may be submitted (via chat function) ... |